Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (618)	11/6/1999 1:08:00 AM
From: Gary Korn	Respond to of 10345

11/5/99 Reuters Eng. News Serv. 12:50:00 (see bold) Reuters English News Service C) Reuters Limited 1999. Friday, November 5, 1999 REPUBLIC OF IRELAND: Irish bourse flat, Elan weak, Ryanair firm. DUBLIN, Nov 5 (Reuters) - The Irish bourse ended Friday barely changed, failing to benefit from a rally on Wall Street after favourable U.S. jobs and wages data eased some interest rate worries, traders said. The ISEQ index of leading Irish stocks ended at 4,609.15 points, down 5.87 points on the day. Gainers outnumbered losers by 17 to 10, with nine stocks unchanged. "On balance, the market didn't trade as well as you might have expected given the decent U.S. figures. It looks like we've run into some end-of-week profit-taking although we haven't seen too much volume in the stocks trading down," one trader said. Among stocks in the news, Bank of Ireland Plc dropped 0.9 percent to 8.04 euros and Irish Life & Permanent Plc shed two percent to 10 euros despite news they were considering a joint bid for Ulster Bank . Dealers said that news was not a surprise but considered the joint bid a favourable move with considerable synergy savings possible for both companies. "We could see some gains there next week," one said. Among major movers, Jefferson Smurfit Group Plc continued to rebound, playing catch-up with its U.S. peers on hopes for better pricing conditions and an Asian recovery. Smurfit ended 3.1 percent higher at 2.7 euros. Pharmaceuticals group Elan Corp Plc was off two percent at 24.20 euros, mirroring heavy losses in the United States although dealers said there was nothing specific moving the often-volatile stock. Gainers included Ryanair Holdings Plc , up 1.6 percent to 7.85 euros on hopes for bullish interim results next week. DCC Plc was up 1.4 percent to 7.1 euros ahead of its first-half results on Monday. ((Tony Roddam, Dublin newsroom +353)

To: blankmind who wrote (618)	11/6/1999 1:09:00 AM
From: Gary Korn	Respond to of 10345

11/5/99 PR Newswire 15:04:00 PR Newswire Copyright (c) 1999, PR Newswire Friday, November 5, 1999 Elan Responds to Recent Stock Volatility - Reaffirms Positive Outlook for 1999 and 2000 - DUBLIN, Ireland, Nov. 5 /PRNewswire/ -- Elan Corporation, plc (NYSE: ELN) ("Elan") states that it knows of no reason for the recent decline of its share price and that it remains comfortable with the high end of consensus estimates for the fourth quarter of 1999 and calendar year 2000. In addition, Elan confirms that all of its major development programs and new product introductions are on track. Elan is a leading worldwide specialty pharmaceutical company headquartered in Ireland, with its principal research, development, manufacturing and marketing facilities located in Ireland, the United States and Israel. Elan shares trade on the New York, London and Dublin Stock Exchanges. /CONTACT: Mary Ansaldi, Director, Investor Relations of Elan Corporation, plc, 212-407-5740, 800-252-3526, mansaldi@elancorp.com/ 14:49 EST ---- INDEX REFERENCES ---- NEWS SUBJECT: PR Newswire; Press Release Wires (PR PREL) MARKET SECTOR: Newswire End Code (NND) Word Count: 107 11/5/99 PRWIRE 15:04:00 END OF DOCUMENT

To: blankmind who wrote (618)	11/6/1999 1:10:00 AM
From: Gary Korn	Respond to of 10345

11/5/99 Dow Jones News Serv. 14:51:00 Dow Jones News Service Copyright (c) 1999, Dow Jones & Company, Inc. Friday, November 5, 1999 Elan Corp. Knows No Reason For Share Price Decline NEW YORK -(Dow Jones)- Elan Corp. (ELN) said it knows of no reason for the recent decline of its stock price, and said it remains "comfortable" with the "high end" of estimates for both its fourth quarter and full year 2000. In a press release Friday, Elan said all of its major development programs and new product introductions are on track. The New York Stock Exchange-listed American depositary receipts of Elan dipped below its 52-week low of 23 15/16 Friday, and recently traded at 23 5/8, down 1, or 4.1%, on volume of 7.4 million shares. Average volume is 1.7 million shares. A First Call/Thomson Financial survey of 12 analysts produced a mean earnings estimate of 35 cents a diluted share for the company's fourth quarter. A survey of 13 analysts produced a mean earnings estimate of $1.50 a share for the company's full year 2000 period. Elan is an Irish specialty pharmaceutical company. -Gregg Henglein; Dow Jones Newswires; 201-938-5400 ---- INDEX REFERENCES ---- COMPANY (TICKER): Elan Corp. PLC; U.ELN (ELN U.ELN) NEWS SUBJECT: Dow Jones News Service; Dow Jones News Wires; American Depository Receipts; High-Yield Issuers; Stock Market News; World Equity Index; Corporate Actions; Earnings Projections (DJN DJWI ADR HIY STK WEI CAC ERP) MARKET SECTOR: Newswire More Code; Consumer Non-Cyclical; Newswire End Code (MMR NCY NND)

To: blankmind who wrote (618)	11/6/1999 1:11:00 AM
From: Gary Korn	Respond to of 10345

11/5/99 Dow Jones Int'l News Serv. 13:06:00 Dow Jones International News Copyright (c) 1999, Dow Jones & Company, Inc. Friday, November 5, 1999 Irish Shares End Down, Led By Elan; ISEQ Overall -0.1% DUBLIN -(Dow Jones)- Irish share prices Friday failed to respond to strength in international markets, ending marginally down on a poor performance from pharmaceutical company Elan. The 79-share ISEQ Overall index closed down 5.87 points, or 0.1, at 4609.15. The narrower ISEQ Financials index was at 6634.56, a loss of 17.78 points, or 0.3%. Over the course of the week, the ISEQ Overall gained 1.9% from last week's close, and the ISEQ Financials were up 4.3%. Traders said the Irish market was dragged down by the heavily weighted Elan, which continued its recent slide, closing down 50 cents at EUR24.20. Elan disappointed investors last week with news about the delay in a migraine drug, and the share is weak in the U.S. "Clearly some people have some worries that aren't simply related to that issue," said one Dublin-based trader. "There might be concern about slippages of other drugs." Bank of Ireland and Irish Life and Permanent confirmed they were in talks to mount a joint bid to acquire Ulster Bank, a unit of National Westminster Bank. Dealers said shares in Bank of Ireland weren't largely affected by the anticipated news, and shares closed down 7 cents to EUR8.04. Irish Life & Permanent, which dealers said enjoyed a run earlier in the week, was down 20 cents at EUR10.00, and Allied Irish Banks was up 5 cents at EUR12.15. Among other blue chips, telecommunications company Eircom was down 2 cents at EUR4.00 in quiet trading. Building materials maker CRH closed down 14 cents at EUR18.04. Cardboard producer Jefferson Smurfit continued to gain, closing up 8 cents at EUR2.70. Dealers said share is moving in line with the sector, which it has been lagging in recent weeks. -By Stacy Forster; 353-1-676-2189; sforster@ap.org

To: blankmind who wrote (618)	11/6/1999 1:11:00 AM
From: blankmind	Read Replies (1) \| Respond to of 10345

from the investor page: Shares Outstanding 264,092,000 Shares Held by Institutions: 182,145,000 (68.%) Short Interest Shares 14,654,798 non-inst shares: 81,947,000 the short interest ratio is becoming high for the actual float and it seems more have been jumping on since the last time short interest was reported on 10/12. gary mentioned nite in a recent post, and when the stock recently rose, the shorts clearly helped in giving the stock a booster push. short interest to non-ist float is then about 18%.